Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NP2GO vs Vida Health

NP2GO
Graded #37

Higher grade

vs+25
Vida Health
Graded #447

Lower grade

The verdict

NP2GO takes it — 80.2/100 to 55.2/100.

NP2GO grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Both molecules across 40 states, but upper-mid pricing and no verification listing.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNP2GO +36
81
45
Dose & formulationNP2GO +40
80
40
Clinical oversightNP2GO +4
79
75
Labs & monitoringNP2GO +17
78
61
FulfillmentNP2GO +20
82
62
Contract termsNP2GO +27
82
55
NP2GO · left barVida Health · right bar

The numbers

MetricNP2GOVida Health
WeighScore80.2/10055.2/100
GradeB−C
Scorecard rank#37#447
Semaglutide$150/moNot disclosed
Tirzepatide$250/moNot disclosed
Coverage40 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
NP2GO

Graded #37 · B−

Strengths

  • Both molecules
  • 40-state footprint
  • Transparent listed pricing

Where it loses points

  • Not LegitScript-verified
  • Upper-mid pricing ($150/$250)
  • Not all 50 states
Vida Health

Graded #447 · C

Strengths

  • Medical Weight Loss program includes anti-obesity GLP-1 medications
  • Pairs medication with behavioral-health coaching and medical management
  • Whole-person care across chronic conditions, sleep, and nutrition
  • Integrates with major health plans, PBMs, and benefit platforms
  • Established virtual chronic-care platform

Where it loses points

  • Distributed mainly via employers and health plans, not direct cash-pay
  • Access usually requires employer or plan sponsorship
  • No public consumer GLP-1 pricing
  • Clinician credentials not detailed publicly
  • Less suited to consumers wanting direct-to-door GLP-1

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard